ABSTRACT Background: Doctors are the main prescribers of medication for the patients. There are many factors that affect prescribing behaviour such as pharmaceutical promotions. Aims & Objective: To assess drug representatives' influence on physician's prescription, to assess physician's attitudes toward drug representative and to study other factors that may affect the prescribing behaviour of physicians. Materials and Methods: A cross-sectional study was conducted among 275 GPs & family physicians working in all primary care centers in KAMC in Central Region in 2011-2012. A self-administered structured questionnaire was used. The questionnaire included questions regarding socio-demographics, clinic work load for physicians, factors influencing prescribing of a new drug including gifts offered by drug representatives, reference sources used for prescribing, CME hour characteristics and sponsorships by drug representatives and physician beliefs about impact of pharmaceutical promotions on prescribing. Results: Of the physicians, 204 filled the questionnaire (response rate 74.2%), nearly 72 % were non-Saudi, 71.6% were staff physicians, and 59.8% had more than 10 years of practice. Guidelines updating and drug characteristics were the most important factors influencing physicians' prescription of a new drug (97.5%, 96.6%) while the least factor influencing their prescribing was drug representatives (41.0%). The most frequent resources used by physicians in case of any problems in prescribing process were textbooks e.g. BNF or MIMS (52.5%), Micromedix (44.7%). According to self-report of physicians, their prescribing behaviours were not affected by visits of drug representatives (43.6 %) while some of them (41.7%) stated that may be they were affected. Over 61% of physicians however believed that other physicians´ prescribing pattern was sometimes affected by drug representatives' influence. There was no correlation between sponsored lectures and influence of prescribing behaviours (p-value 0.914). Although the physicians accepted gifts, drug representatives do not influence their prescription of a new drug. Conclusion: A minority of physicians was partially influenced by drug representative promotions affecting their prescribing patterns. Most of the doctors were not affected by gifts or drug related information given by the representatives. Majority of physicians relied on latest guidelines from medical literature and other standard references in writing prescriptions.
Introduction
Doctors play an important role in the health system. They are the main access for prescribing medication to their patients. In both developed and developing countries, prescription of medication is one of the most important factors in the raising costs of health services. [1] A drug is prescribed for more than 60% of the population in Western Europe [2, 3] compared to 75 % of consultation in Saudi Arabia that end with a prescription [4] .
Appropriate prescribing is a balance of a whole picture of patient (which includes personal biography, needs, social situation and disease status) and the choice of medication (which is scientific and pharmacological properties). [5] There are many factors that affect prescribing behaviour other than scientific knowledge. [6] Some of these factors are scientific journal articles that reports drug characteristics [7] , level of education [8] , ethnicity of doctor and of the patient [9] , behaviour of colleagues including hospital doctors [10] , patient's requests for medication [11] [12] [13] , advertising in medical journals and pharmaceutical company promotions [11] [12] [13] [14] [15] and higher number of patients examined per day [16] .
Physicians believed that commercial sources had little effect on 68% of them while 54% of them believed that pharmaceutical representatives were minimally important in choosing prescriptions. In comparison 62% believed scientific evidence was very important in influencing their prescribing behaviour. However, 88% of physicians believed that training and clinical experience was the most important factor in their prescribing habits. [17] There is a wide range of activities of these companies such as gifts, printed materials, drug sample, meals and trips. Pharmaceutical companies sometimes offer symposia, scholarships and even fellowships to physicians in hope to influence their prescribing patterns. [18] [19] [20] [21] [22] [23] [24] [25] Several studies showed that pharmaceutical promotions had great influence on the prescribing behaviour of physicians. [26] [27] [28] [29] [30] In the United States, the pharmaceutical companies spent over $12 billion in 1998 for promotional activities which increased to almost $15.7 billion in 2000 [31, 32] and up to RESEARCH ARTICLE 57.5 billion in 2004. [33] The UK pharmaceutical industry spent around £1.65 billion a year on their marketing. [34] The global pharmaceutical company grows every year, and between 2006 and 2007 it increased by 6.4% to $ 712 billion. [35] Eric G. et al in a survey about physician ~ industry relationship found that most of these relationships involved receiving food (83%) or drug samples (78%). [36] In New Zealand, gifts have been seen as desirable by their General Practitioners. [37] Pharmaceutical companies claim that their activities provide scientific information including benefits and risks of their products [38] , although it is known that some of these information are selective and provide inadequate knowledge about their safety in the community .Furthermore, for developing countries´ doctor, the quality of drug information given is poorer than those in developed countries. [39, 40] United Kingdom generated the most important body for regulation of interactions with the medical profession, which is Association of the British Pharmaceutical Industry. It included that any gifts given to physicians must be of a value of less than £6. These regulations must be more understandable and implemented to reach the goal. [41] There are limited studies from other Gulf countries talking about physicians´ prescribing behaviours. MA Magzoub et al., studied the determinants of physicians' medication prescribing behaviour in primary care in Riyadh city, Saudi Arabia and found that many physicians reported that pharmaceutical companies had positive influence. [42] Research conducted on physicians attitudes and believes indicates that they are often unaware of potential impact of pharmaceutical companies' activities on their attitudes and behaviours. [43] [44] [45] In our study, we aimed to determine the impact of pharmaceutical promotions and activities on primary health care physicians´ prescribing behaviour in KAMC in central region and to assess drug companies' influence on physicians' prescription.
Materials and Methods
This was a cross-sectional study conducted by using selfadministered questionnaire It was conducted with participation of Family Medicine specialists and Staff Physicians (generalists) working in all primary care centers in KAMC in CR (Hail, Rafha, Arar, Riyadh, Qassim and Najran). Specialists, residents, interns as well as students were excluded from participation.
For 95% Confidence Interval, a proportion of 50% of physician being influenced by drug representatives, (16) with a desired precision of ± 5%, gave an estimated sample size of 160, from a finite population of 275 physician of the Department of Family Medicine & PHC. Adjusted up for response rate of 80%, the required sample size was calculated to be 200.Questionnaire was sent to all physicians (275) and 204 responded (74.2%).
Participants for the study were selected by Convenient Non-random Sampling. All physician population in the department of Family Medicine & Primary Health Care was included in the study, fulfilling the inclusion criteria. The study was conducted in 2011 & 2012. Self-administered structured questionnaires distributed to the GPs & family physicians with the help of the research coordinator in family medicine department in KAMC within a period of 3-4 months. It was ensured that physicians filled the questionnaires, by following up by emails and phone calls.
The questionnaire was designed by the researcher based on literature review and was prepared in English language. The questionnaire included the following items; Sociodemographic data that included: (Age, gender, nationality, qualification, job title, years of practice after MBBS), clinic work load for physicians, factors influencing prescribing of a new drug including gifts offered by drug representatives, reference sources used for prescribing, CME hours characteristics and sponsorships by drug representatives and physicians' beliefs about impact of pharmaceutical companies on prescribing.
Content validity was carried out by two experienced Family Medicine physicians. A pilot study was conducted on 15 physicians to check the appropriateness and clarity of the questionnaire. Based on this pilot study, the questionnaire was modified to its final version.
All data were entered in the computer using the SPSS software, version 18, followed by data cleaning. Descriptive statistics including frequency, percentages, mean and standard deviation were calculated. Variables were cross-analyzed using Chi-square. P value under 0.05 was considered to be significant. This study was conducted on human participants. All data were maintained in a secure fashion without mentioning the names of physicians who handed in the envelope or returned it back to the secretary. All data were analyzed as a total population in a manner that we maintained individual privacy. All records with results and progress both electronic & written will be maintained with the researchers for a minimum period of two years in case of review. Upon completion of the study the final report will be submitted to the Saudi Commission for Health Specialization. All participants who were interested in knowing our results were requested to write their e-mail addresses in the space provided in the questionnaire handed to them. Participants were informed that their contact information will stay confidential and be used for that purpose only.
Ethical approvals were obtained from the Institutional Review Board of National Guard Health Affairs and the departmental Family Medicine Research Committee prior to conducting the research. Project research proposal was approved by the King Abdullah International Medical Research Center.
Results
Questionnaires were sent to all physicians (275) and 204 responded giving a response rate of 74.2%. Table 1 shows socio-demographic data among respondents. It shows that 71.6% of them were non-Saudi, 71.6% were staff physicians, and 59.8% had more than 10 years of practice. Most physicians (81.8%) saw between 10-40 patients per day with time spent per patient around 5-15 minutes among 90.1% of them. Table 2 shows that updated guidelines and drug characteristics are the most important factors influencing physicians' prescription of a new drug (97.5%, 96.6%) while the least factor influencing their prescribing is drug representatives (41.0 %). The most frequent resources used by physicians in case of any problems in prescribing process were text books e.g. BNF or MIMS (52.5%), Micromedix (44.7%) while documents and drug guides from drug representatives were the least frequent used resources. Most physicians (57.4%) attended more than 30 CME hours per year. (60.3%) of these CME hours were selfsponsored, (41.7%) of physicians attended around 1-2 lectures/symposia sponsored by drug companies. Figure 1 shows that (66.7 %) of physicians accepted office supply from drug representatives, (60.8%) accepted drug samples, (65.7%) accepted meals and (22.1 %) accepted trips. Nearly 20% of physicians feel that gifts offered by drug representatives affected their prescription of a certain drug. Nearly 60% of physicians think that they gain more information about a certain drug from drug representatives and 81.4% of physicians claim that they are confirm the accuracy of the information given to them. Almost a similar number of physicians reported that their prescription was not affected by visits of drug representatives or may be affected (43.6% Vs. 41.7%) while 61.3% of physicians believed that other physicians´ prescribing pattern is sometimes affected by drug representatives' influence. There was no correlation between socio-demographic data of physicians and drug representatives' influence in prescribing new drugs. In addition, the results demonstrates no statistical differences between busy clinics or time spent with patients and drug representatives' influence in prescribing new drugs.
As illustrated in table 3, physicians who thought that drug samples are an acceptable gift, were likely to prescribe a drug based on drug representative influence. Table 4 shows that physicians who think that they gained information from drug representatives; their prescribing may be affected by them (p-value <0.001). Physicians who think that they gained information from drug representatives were actually influenced by them in prescribing new drug (p-value 0.001). All kinds of gifts, meals, samples, and sponsored trips affected prescribing of new drug by the physicians (Table 5 ).
Physicians who think that they gain less information from drug representatives were less frequently visited by them (p-value 0.002) as shown in table 6. Physicians who didn't accept meals, trips or drug sample from drug representatives, their prescription were less likely to be affected by their offer (p-value < 0.05). Physicians do not seem to be impressed by office supplies offered by the drug companies (Table 7) . Physicians who believed that they gained less information from drug representatives were less likely to prescribe new drug (p-value 0.010) ( Table 8 ). Table 9 shows that physicians who believed that they gained information from drug representatives were less likely to confirm the accuracy of information, however the relationship was not significant. 
Figure-1: Gifts offered and accepted by drug representative in percentage Discussion
Prescription of medication is one of the most important factors in the raising costs of health services. There are many factors that affect the prescribing behaviour other than the scientific knowledge. One of these factors is pharmaceutical company promotions.
We conducted this cross sectional study to explore the impact of pharmaceutical promotions on physicians' prescribing behaviour in all PHC physicians in KAMC in CR. A total of 204 questionnaires were collected from 275 physicians in CR.
Looking at physician's characteristics, we observed that majority of them were non-Saudis, working as staff physicians, and around 59.8% had more than 10 years of practice. The age groups and the gender groups among physicians were almost equal in percentages.
According to self-report of physicians, their prescribing behaviours were not affected by visits of drug representatives (43. There might be an underestimation of the effect of pharmaceutical promotion on the prescribing decision of physicians in our study or this could be related to the rules and regulation of our institute regarding prescribing and dealing with drug representatives that limit their influence. As mentioned before, some of physicians (41.7%) stated that might be affected by drug representatives' visits and the percentage was almost similar to those who were not affected. That can be explained that they were uncertain about the influence of pharmaceutical promotion or they were unsure about their behaviour towards them.
In our study, there was no statistical difference between socio-demographic data of physicians & drug representative's influence in prescribing new drugs. Unlike Prosser et al, where they found that if GP's were working at PHC centers & had an experience of less than 5 years after graduation, they were more likely to be influenced by drug representatives. [15] We did not find any correlation between busy clinics or limited time-per-patient & drug representative's influence in prescribing new drugs which is also an opposite finding to Prosser study. [15] The most accepted gifts by physicians in our study were drug samples, meals & office supply which was almost similar to other studies. [46] In our study, with the exception of office supplies, all other gifts had an influence on prescribing habits of physicians.
Most physicians (57.4%) attended > 30 CME hours/ year following the recommendation from Saudi commission for physician registration and although (41.7%) of physicians attended sponsored lectures in the last year, there was no correlation between sponsored lectures and influence of prescribing behaviours. The explanation behind these findings may be because our study was conducted in KAMC which is a big institute and it offered these sponsored activities to their physicians with no direct relationship with drug representatives and that there were strong policies regarding drug representatives' visits & prescribing process.
Guidelines updating & drug characteristics were the most important factors found in our study to have an effect on physicians' prescribing. Similar results were found by Orlowski & Wateska [27] , were physicians appeared to believe that any decision to prescribe a drug is based on scientific data, clinical experience & patient's needs rather than on promotion by pharmaceutical companies.
Furthermore, text books e.g. BNF or MIMS and micromedix were the most commonly used reference resources by physicians (52.5%) in case of having any problem in prescribing, while documents and drug guides from drug representatives were one of the least frequent used resources (29.8%). In USA, a survey was done by FDA, showed that (80%) of GP's used documents and drug guides provided by drug representatives as a source of drug information and a visit of representatives was used as an information source by (61%) of them. [47] Our finding may be explained by the strong regulations and guidelines for updating medical knowledge in our institute, the visits of drug representatives being less frequent, and the unfriendly attitude of some physicians towards drug representatives.
These findings emphasize the importance of providing physicians in Saudi Arabia with ongoing training in drug prescribing, in addition to access to relevant educational materials. As previously emphasized, the purpose was to open up this area of research and to provide guidance to other researchers who may wish to develop these analyses in Saudi Arabia and beyond.
It is important to recognize that this study had some limitations. The questionnaire reflects PHC physicians' 
Conclusion
In conclusion, a minority of physicians was partially influenced by drug representative promotions affecting their prescribing patterns. Most of the doctors were not affected by gifts or drug related information given by the representatives. Majority of physicians relied on latest guidelines from medical literature and other standard references in writing prescriptions. In the light of our results, we recommended providing training in drug prescribing to PHC physicians, in addition to access to relevant educational materials. Also, we recommended studying the true impact of pharmaceutical promotion through conducting another research measuring the direct effect of drug promotion by checking prescription of a specific drug pre and post exposure to drug representative visit or to promotion of any kind of that specific drug.
ACKNOWLEDGMENTS
The author would like to gratefully acknowledge and appreciate Dr. Muneera Baraja, Consultant Family and Community Medicine NGCSC for her great support, enthusiasm and encouragement throughout the study conduction.
